cKNGRE Pep-LNP

Name: cKNGRE Pep-LNP
SKU: TDLD-0126-LD71
Rating: 5 (1 reviews)

Cat. No.: TDLD-0126-LD71

cKNGRE Pep-LNP

cKNGRE Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) designed for targeted therapeutic delivery. The cKNGRE peptide, a cyclic sequence (Cyclo(Lys-Asn-Gly-Arg-Glu)), binds integrins in tumor vasculature, enabling active targeting. DSPE-PEG modification enhances tumor accumulation, suitable for cancer therapy research. Please note that this product is intended for research purposes only.

Inquiry

SPECIFIC INQUIRY

Payload:

Modification:

Lipid Formulation:

Dye:

Concentration:

Quantity:

Clear All Inquiry

For Research Use Only. Not for Diagnostic or Treatment Applications.

Payload Type	mRNA
Payload	Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others
Capping	Cap 1
Modification	Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other

Module Type	Peptide
Targeting Module	cKNGRE Peptide

Target	Integrin receptors
Lipid Formulation	DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other
Dye	Unlabeled; DiR; DiD; DiO; DiI; Other
Application	Control; Targeted Delivery; Gene Therapy
Format	Liquid
Concentration	0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)

Size	65-120 nm
PDI	< 0.2
Zeta	± 20.0 mV
Encapsulate Efficiency	>90%

Shipping	Dry Ice
Storage	Store at -80°C